0
0.0
May 1, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
gsk raised its guidance. haleon is broadly higher. s sylvia is here. >> they're up by 1.6%, this isais after the company announced this morning it's increased its turnover expectations for the year. it says it will be in the upper part of the 5% to 7% range they had guided earlier, but they also said profit operating growth will be in the range of 9% to 11% real estate than the previous 10% to 11%. the first quarter came in at slightly above what analysts were expecting at 7.3 billion pounds, however, the company also said in the first quarter, they had to account for significant legal charges related to the litigation, however, some analysts suggest that the process could be concluded at some point this year. the ceo also said in a statement this morning that she expects this strong momentum to continue and looks forward to other meaningful growth. other analysts have said they still think the stock is likely to underperform this year. they believe that their pipeline is not sufficient to actually offset some of the risks when it com
gsk raised its guidance. haleon is broadly higher. s sylvia is here. >> they're up by 1.6%, this isais after the company announced this morning it's increased its turnover expectations for the year. it says it will be in the upper part of the 5% to 7% range they had guided earlier, but they also said profit operating growth will be in the range of 9% to 11% real estate than the previous 10% to 11%. the first quarter came in at slightly above what analysts were expecting at 7.3 billion...
0
0.0
May 21, 2024
05/24
by
BBCNEWS
tv
eye 0
favorite 0
quote 0
in a statement, gsk said it will defend against what it called a "meritless lawsuit". singapore airlines says that one passenger onboard a flight from london died and several others were injured when the plane encountered severe turbulence. the flight, which was bound for singapore, was forced to make an emergency landing in bangkok. 0ur south east asia correspondentjonathan head is on the line. bring us up—to—date on what we know so far. we bring us up-to-date on what we know so far. ~ ~' ., bring us up-to-date on what we know so far. ~ ~ ., , ., ., so far. we know the plane landed about two hours _ so far. we know the plane landed about two hours ago _ so far. we know the plane landed about two hours ago in _ so far. we know the plane landed about two hours ago in bangkok. | so far. we know the plane landed | about two hours ago in bangkok. it is at the airport now. there were a lot of ambulances sent in to deal with those who had been injured. everyone on board who was hurt they are off the plane and all those injured will be treated. we have had confirmed one f
in a statement, gsk said it will defend against what it called a "meritless lawsuit". singapore airlines says that one passenger onboard a flight from london died and several others were injured when the plane encountered severe turbulence. the flight, which was bound for singapore, was forced to make an emergency landing in bangkok. 0ur south east asia correspondentjonathan head is on the line. bring us up—to—date on what we know so far. we bring us up-to-date on what we know so...
0
0.0
May 21, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
gsk is off1.43% on the news. on that note, let's give it back to you, rank. >> carolin, thank you. >>> turning our attention back stateside and stocks making moves ahead of the open. silvana is here with the big money movers. >> good morning, frank. we start with zoom. it is lower in the pre-market after the second quarter forecast came in below estimates. we are seeing losses of 1% right now. that's despite a more than upbeat longer-term outlook. the company says it is pushing to inn corporate artificial intelligence and broad range of services has so far been successful. meanwhile, let's move to palo alto networks. sinking down 8.10%. forward guidance disappointing as companies pullback on cyber spending. the ceo on "mad money" last night saying there was nothing wrong the quarter. >> revenue was great. profitability was amazing. our free cash flow margins are great. i don't think there is anything wrong with the quarter. >> shares of peloton under pressure. down .70% in the pre-market. the company announcing g
gsk is off1.43% on the news. on that note, let's give it back to you, rank. >> carolin, thank you. >>> turning our attention back stateside and stocks making moves ahead of the open. silvana is here with the big money movers. >> good morning, frank. we start with zoom. it is lower in the pre-market after the second quarter forecast came in below estimates. we are seeing losses of 1% right now. that's despite a more than upbeat longer-term outlook. the company says it is...
0
0.0
May 9, 2024
05/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
they will be in third place behind gsk and pfizer who already have rsv vaccines on the market, a head start and experience with selling vaccines to big pharmacy chains which is where a lot of the rsv market is. that is something moderna has not had experience doing. the government bought their covid vaccine in bulk. now they have to learn how to go out and sell shot. katie: some boots on the ground to sell the shot. covid sales going down. they have rsv. maybe they will be in third place. what else is in the pipeline? gerry: they are working on more than 30 drugs. they are relying on this technology that they believe in. one of the most ambitious parts of their pipeline is cancer treatments. they have promising data on the melanoma vaccine, the most advanced cancer treatment. it could be a lucrative opportunity for them if it works out. katie: if it works out. that is a big if. we have promising data but in terms of actually getting a product to the market, how far away with something like that be? gerry: moderna, their are substeps they have to take with their melanoma vaccine. they
they will be in third place behind gsk and pfizer who already have rsv vaccines on the market, a head start and experience with selling vaccines to big pharmacy chains which is where a lot of the rsv market is. that is something moderna has not had experience doing. the government bought their covid vaccine in bulk. now they have to learn how to go out and sell shot. katie: some boots on the ground to sell the shot. covid sales going down. they have rsv. maybe they will be in third place. what...
0
0.0
May 1, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
slightly above what analysts were expecting and perhaps even more important for investors is the fact that gsk actually raised their guide answer for the year. but let me take you to the end of the month performance. it's an important moment to really assess what happened throughout april, and you can see that among all of the major places in europe, ftse was the only one that ended by 2.4%. some of the reasons behind that include a weaker sterling, but also momentum when it comes to miners and oil stocks. this was the picture at the end of the month. we had basic resources outperforming therest of the market, up by almost 10%. one of the reasons behind that was the attempt by bhp to buy anglo american. anglo american refused that offer, however, it did shed light that perhaps some uk stocks are actually cheap and, therefore, there's the potential for some dealmaking. it came in from autos, down by more than 6% for the month. some of the corporate releases, particularly volkswagen didn't help the sector. let's see what else happens for the month of may. >>> we're going to turn our attention no
slightly above what analysts were expecting and perhaps even more important for investors is the fact that gsk actually raised their guide answer for the year. but let me take you to the end of the month performance. it's an important moment to really assess what happened throughout april, and you can see that among all of the major places in europe, ftse was the only one that ended by 2.4%. some of the reasons behind that include a weaker sterling, but also momentum when it comes to miners and...
0
0.0
May 21, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
. >>> gsk has reported positive results from the phase three trials of the drug depemokimab. the drug is not yet approved anywhere the world and could be a growth driver by the end of the decade and forecasting sales of 3 billion pounds. >>> and price inflation fell for the 15th month in a row. the lowest level since october of 2021. annual grocery price inflation came in at 2.4%, down from 3.2% a month earlier. >>> and german fromproducer pri fell 3.1% for the year. let's get to annette weisbach with more. >> reporter: i think it is a positive sign for the ecb that producer prices here in germany is the biggest economy of the eurozone which is on the decline for the tenth consecutive month. c producer prices are the rule for the economists where 30% of the producer prices are factored into the consumer price inflation. we see a clear downward trajectory which should give the ecb a good feeling about cutting rates in june. the rate cut as such is given for june, but the key question is what happens afterwards and how much will they cut? why are producer prices on the decline
. >>> gsk has reported positive results from the phase three trials of the drug depemokimab. the drug is not yet approved anywhere the world and could be a growth driver by the end of the decade and forecasting sales of 3 billion pounds. >>> and price inflation fell for the 15th month in a row. the lowest level since october of 2021. annual grocery price inflation came in at 2.4%, down from 3.2% a month earlier. >>> and german fromproducer pri fell 3.1% for the year....
0
0.0
May 9, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
. >> well, granola, you've got gsk, you've got r ooche >> nestle. a couple of ns they really bent the rules >> people have done that in our game, as well. i won't name names, but -- >> but the point is they are very interesting companies >> and it's essentially an a anti-technology bet. >> yes >> it's all about europe's no w weighting in technology, heavy weighting in big banks, not a lot in retail. it's a very different index than the s&p. it's a value story >> yeah. there's no question. and if we've been struggling -- mag sevens are having trouble making new highs and i think it's wait for nvidia to really see what happens i think it's interesting >> there is one company leaving europe, coming to the new york stock exchange, which is flutter. i know tim knows it very well, which is fan dual, and they're going to be listed on new york, they're moving from the lse here, end of may, they report numbers. we see what's going on with wagering the money in the kentucky derby. much cheaper than draft kings, so -- >> it trades half the multiple of draftkin
. >> well, granola, you've got gsk, you've got r ooche >> nestle. a couple of ns they really bent the rules >> people have done that in our game, as well. i won't name names, but -- >> but the point is they are very interesting companies >> and it's essentially an a anti-technology bet. >> yes >> it's all about europe's no w weighting in technology, heavy weighting in big banks, not a lot in retail. it's a very different index than the s&p. it's a...